Back

The future of lipid management: new therapies for LDL-C lowering

31 August 2019 (16:15 - 16:35)
Organised by:
Congress Presentation Part of: Targeting of PCSK9 with siRNA for LDL-C reduction in a high-risk population Coronary Artery Disease (Chronic) / Chronic Coronary Syndromes (CCS) ESC Premium Access ESC Congress 2019

About the speaker

Photo
Doctor Harold Bays

Louisville Metabolic and Atherosclerosis Research Center, Louisville (United States of America)

4 More presentations in this session

Presentation thumbnail
Clinical implications for patients at persistent ASCVD risk
Doctor J. Saseen (Aurora, US)
Slides Video
Presentation thumbnail
Clinical trial updates
Doctor C. Ballantyne (Houston, US)
Slides Video
Presentation thumbnail
Post-activity quiz and discussion
Doctor P. MORRIS (Charleston, US)
Slides Video
Presentation thumbnail
Questions and answers / Panel discussion
Slides Video

Access the full session

Session thumbnail
Targeting of PCSK9 with siRNA for LDL-C reduction in a high-risk population

The Event

Event poster

ESC Congress 2019

31 August 2019 16:15 CET
You may be interested in
thumbnail
Congress Presentation
How to manage lipid risk pharmacologically – new approaches
13 April 2023
thumbnail
Congress Presentation
Forging the path: strategic combinations to achieve lipid targets
29 August 2025
thumbnail
Congress Presentation
Breaking through: CETP inhibitors and the future of lipid therapy
29 August 2025
thumbnail
Congress Session
A new chapter in lipid control: expanding the therapeutic horizon
29 August 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources